Interparfums, Inc. filings document formal disclosures for a global prestige fragrance company that develops, produces and distributes fragrance and fragrance-related products under license and other agreements with brand owners. Recent 8-K reports incorporate operating results, net sales, consolidated income and balance-sheet data, cash flow, inventory, long-term debt, guidance, and Regulation FD updates on product innovation and market conditions.
The company's filings also record material brand-license matters, including GUESS?, Nautica and David Beckham agreements, and a Form 12b-25 notification related to annual-report timing. These records frame disclosure around European based operations through Interparfums SA, United States based operations through subsidiaries in the United States and Italy, portfolio management, financial reporting, and forward-looking information.
Interparfums, Inc. (IPAR) announced initial fiscal 2027 guidance, projecting net sales of approximately $1.58 billion, up 6%, and diluted EPS of approximately $5.00, up 3%. The 2026 estimates are $1.49 billion in net sales and $4.85 in diluted EPS; the EPS estimate includes a one-time $17.9 million gain, or $0.35 per diluted share, related to IEEPA tariff refunds. The 2027 guidance assumes no comparable benefit; excluding the 2026 benefit, diluted EPS is estimated to increase approximately 11%.
Sales growth is expected to reflect leading brands, new-brand debuts and product launches, partly offset by softer performance from smaller brands, licenses expiring at the end of 2026 and 2027, and challenges in the Middle East and Eastern Europe. The outlook assumes an approximately 1% unfavorable foreign-exchange impact on sales. EPS growth is expected to be partly offset by elevated brand investment and marketing spending for 2027 launches and 2028 innovation initiatives.
Interparfums, Inc. (IPAR) reported third-quarter net sales of $430 million, flat year over year, while operating income rose 9% to $118 million and diluted EPS increased 4% to $2.13. Gross margin expanded 360 basis points to 67.1%. For the first nine months, sales were $1.115 billion, up 1%, and net income attributable to Interparfums was $142 million, up 1%.
The company raised 2026 sales guidance from $1.48 billion to $1.49 billion and maintained diluted EPS guidance of $4.85. Operating cash flow for the first nine months reached $102 million, compared with $68 million in the prior-year period. In the third quarter, Interparfums invested approximately $50 million to acquire additional shares of its majority-owned subsidiary Interparfums SA, raising its ownership from approximately 72.5% to 74.3%; it continues to control and consolidate the subsidiary. A regular quarterly cash dividend of $0.80 per share is payable December 31, 2026, to shareholders of record December 15, 2026.
Interparfums, Inc. reported third-quarter 2026 net sales of $429.5 million, compared with $429.6 million a year earlier, and net income attributable to its common shareholders of $68.2 million versus $65.8 million. For the first nine months, sales were $1,115.4 million versus $1,102.3 million, and attributable income was $142.1 million versus $140.3 million. Third-quarter gross margin was 67.1%, compared with 63.5%; the company cited favorable mix, lower destruction costs and tariff refunds, partly offset by tariffs.
U.S.-based third-quarter sales fell 7% as supply-chain delays moved approximately $10 million in giftset shipments into the fourth quarter; excluding those delays, sales would have been flat. Nine-month operating cash flow was $102.3 million, versus $68.4 million. In the third quarter, the company invested approximately $49.5 million to acquire additional Interparfums SA shares, raising its ownership from approximately 72.5% to 74.3%, and extended the Roberto Cavalli fragrance license through December 31, 2046. As of September 30, 2026, it had drawn €55.0 million under a €200 million delayed-draw facility, with €145.0 million available. As of September 30, 2026, it had received $17.3 million of IEEPA tariff refunds; $14.8 million reduced cost of sales and $1.0 million reduced selling, general and administrative expenses.
Interparfums, Inc. reported third-quarter 2026 net sales of $430 million, flat with the prior-year quarter; net sales for the first nine months were $1.115 billion, up 1% from $1.102 billion. European-based net sales were $306 million, up 4% from $295 million, while U.S.-based net sales were $127 million, down 7% from $137 million.
Management attributed the U.S. quarterly decline largely to supply-chain disruptions that delayed giftset shipments for select brands; approximately $10 million in sales will now be recognized in the fourth quarter of 2026. Management said U.S.-based sales would have been flat for the quarter and up 6% for the first nine months excluding the delayed shipments. European operations' quarterly increase included 3% organic growth and a 1% contribution from new brands, partially offset by a 1% foreign-exchange headwind. The dollar/euro rate changes led to a 0.4% foreign-exchange loss for the quarter and a 1.5% gain for the first nine months. Management maintained a measured but positive outlook for the balance of 2026 and 2027.
Interparfums, Inc. (IPAR) announced that it has entered into an exclusive, worldwide license agreement with sports company PUMA for the creation, development, production, and distribution of fragrances under the PUMA brand. The license runs through December 31, 2037, providing a long-term framework for collaboration.
Interparfums plans to introduce a new signature lifestyle fragrance under the PUMA brand in 2027. The agreement adds PUMA to Interparfums’ portfolio of licensed prestige brands, which are managed through its European operations, led by its 72% owned subsidiary Interparfums SA, and its United States operations.
Interparfums, Inc. (IPAR) announced a 20-year extension of its exclusive worldwide license agreement with Marquee Brands for Roberto Cavalli and Just Cavalli fragrances, extending the partnership through December 31, 2046. The agreement covers ongoing creation, development and global distribution of these fragrances.
Management highlighted Roberto Cavalli as one of the fastest-growing brands in the portfolio, supported by recent launches such as the 2025 blockbuster fragrance Serpentine and a pipeline of upcoming launches. The licenses will continue to be operated by Interparfums Italia Srl, the wholly owned Italian subsidiary with operations in Florence and management based in Paris.
INTERPARFUMS INC (IPAR) filed an amended Form 3 to update the initial statement of beneficial ownership for director Valerie Hermann. The amendment adds a previously omitted Power of Attorney to the record and reports no insider transactions or holdings changes.
INTERPARFUMS INC (IPAR) filed an amended Form 3 to update the initial insider ownership report for director Benedicte Epinay.
The amendment states that a Power of Attorney was inadvertently omitted from the original Form 3 filed earlier the same day and is now being added to the record, without reporting any security holdings or transactions.
Interparfums, Inc. (IPAR) reported results of its September 15, 2026 annual meeting of stockholders, where all proposals were approved. Shareholders elected a nine-member Board of Directors, including two new independent directors, Valérie Hermann and Bénédicte Epinay, to serve one-year terms until the next annual meeting.
Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers, and approved a ten-year extension of the term of the company’s 2016 Stock Option Plan to June 27, 2036. No broker non-votes were recorded on the reported proposals.
INTERPARFUMS INC (IPAR) reported that Valerie Hermann, a director of the company, has filed an initial statement of beneficial ownership on Form 3. The submission does not list any equity holdings or derivative positions for her at this time.